BioSpace News Archive

PharmaEssentia Corporation, announced the appointment of Lih-Ling Lin, PhD, as Chief Scientific Officer as of August 1st.

Edesa Biotech, Inc. announced today that its executive management will participate in the upcoming BTIG Biotechnology Conference being held in New York, NY on August 8-9, 2022.

Theseus Pharmaceuticals, Inc. today announced that it will participate virtually in the 2022 Wedbush PacGrow Healthcare Conference, taking place August 9-10, 2022.

EpicentRx Inc. has published a commentary in one of the top infectious disease journals, International Journal of Infectious Disease, emphasizing the importance of a “universal” coronavirus vaccine based on the nucleocapsid or N protein instead of the spike or S protein, which is used in current COVID vaccines.

A new study on the effectiveness of plant-based organs for use in surgical training was performed by Dr. Naoki Nishio at the Nagoya University Graduate School of Medicine.

Biora Therapeutics, Inc . (Nasdaq: BIOR), the biotech company that is reimagining therapeutics, today announced the acceptance of five abstracts for presentation at the American College of Gastroenterology (ACG) 2022 Annual Scientific Meeting.

Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) today announced the completion of the SAD portion of the Phase 1 study of its oral main viral protease (Mpro) inhibitor, the STI-1558.

Brand Institute’s President of its Nonproprietary Naming Division, Sophia Fuerst, M.S., M.B.A., is pleased to offer summary insights regarding recently implemented procedures for international nonproprietary names (INNs), specifically INNs for Variant COVID-19 Vaccine Active Substances.

Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), a biopharmaceutical company developing innovative medicines based on cancer cell biology, will announce second quarter 2022 financial results on Wednesday, August 10, 2022.

DetectaChem and its subsidiary MD-Bio, the global leaders in innovative threat detection solutions used extensively by the U.S. Department of Defense, U.S. Homeland Security, law enforcement, first responders and public health agencies around the world, announce the launch of their MD-Bio qPCR Monkeypox Detection Assay.